HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Advances in the research of melatonin in autism spectrum disorders: literature review and new perspectives.

Abstract
Abnormalities in melatonin physiology may be involved or closely linked to the pathophysiology and behavioral expression of autistic disorder, given its role in neurodevelopment and reports of sleep-wake rhythm disturbances, decreased nocturnal melatonin production, and beneficial therapeutic effects of melatonin in individuals with autism. In addition, melatonin, as a pineal gland hormone produced from serotonin, is of special interest in autistic disorder given reported alterations in central and peripheral serotonin neurobiology. More specifically, the role of melatonin in the ontogenetic establishment of circadian rhythms and the synchronization of peripheral oscillators opens interesting perspectives to ascertain better the mechanisms underlying the significant relationship found between lower nocturnal melatonin excretion and increased severity of autistic social communication impairments, especially for verbal communication and social imitative play. In this article, first we review the studies on melatonin levels and the treatment studies of melatonin in autistic disorder. Then, we discuss the relationships between melatonin and autistic behavioral impairments with regard to social communication (verbal and non-verbal communication, social interaction), and repetitive behaviors or interests with difficulties adapting to change. In conclusion, we emphasize that randomized clinical trials in autism spectrum disorders are warranted to establish potential therapeutic efficacy of melatonin for social communication impairments and stereotyped behaviors or interests.
AuthorsSylvie Tordjman, Imen Najjar, Eric Bellissant, George M Anderson, Marianne Barburoth, David Cohen, Nemat Jaafari, Olivier Schischmanoff, Rémi Fagard, Enas Lagdas, Solenn Kermarrec, Sophie Ribardiere, Michel Botbol, Claire Fougerou, Guillaume Bronsard, Julie Vernay-Leconte
JournalInternational journal of molecular sciences (Int J Mol Sci) Vol. 14 Issue 10 Pg. 20508-42 (Oct 14 2013) ISSN: 1422-0067 [Electronic] Switzerland
PMID24129182 (Publication Type: Journal Article, Review)
Chemical References
  • Melatonin
Topics
  • Animals
  • Child Development Disorders, Pervasive (metabolism, physiopathology, therapy)
  • Communication Disorders (metabolism, physiopathology, therapy)
  • Humans
  • Melatonin (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: